Silent coronary artery disease in type 2 diabetes mellitus: the role of Lipoprotein(a), homocysteine and apo(a) polymorphism

BACKGROUND: There is little data on the relationship between novel cardiovascular risk factors and silent coronary artery disease (CAD) in diabetic patients. We investigated whether Lipoprotein(a), homocysteine and apolipoprotein(a) polymorphism are associated with angiographically assessed asymptom...

Deskribapen osoa

Xehetasun bibliografikoak

Argitaratua izan da:	Cardiovasc Diabetol
Egile Nagusiak:	Gazzaruso, Carmine, Garzaniti, Adriana, Giordanetti, Stefano, Falcone, Colomba, Fratino, Pietro
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMC 2002
Gaiak:	Original Investigation
Sarrera elektronikoa:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC149426/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12473160/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1475-2840-1-5
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!